Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned
This article was originally published in The Tan Sheet
Executive Summary
FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners